|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4985 | (2006.01) |
| A61K 31/4985 | (2013.01) | ||
| A61P 31/12 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 31/44 | (2013.01) | ||
| A61K 31/44 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| G01N 33/50 | (2006.01) |
| (11) | Patento numeris | 3641772 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 18819790.9 |
| Europos patento paraiškos padavimo data | 2018-06-21 | |
| (97) | Europos patento paraiškos paskelbimo data | 2020-04-29 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2023-08-02 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2018/038697 |
| Data | 2018-06-21 |
| (87) | Numeris | WO 2018/237114 |
| Data | 2018-12-27 |
| (30) | Numeris | Data | Šalis |
| 201762523688 P | 2017-06-22 | US |
| (72) |
FILVAROFF, Ellen , US
HEGE, Kristen, M. , US
LI, Shaoyi , US
|
| (73) |
Celgene Corporation ,
86 Morris Avenue, Summit, NJ 07901,
US
|
| (54) | TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION |
| TREATMENT OF HEPATOCELLULAR CARCINOMA CHARACTERIZED BY HEPATITIS B VIRUS INFECTION |